Occupational Inhalational Exposure and Serum Gm-Csf Autoantibody in Pulmonary Alveolar Proteinosis

Yong-Long Xiao,Kai-Feng Xu,Yan Li,Hui Li,Bin Shi,Ke-Feng Zhou,Zheng-Yang Zhou,Hou-Rong Cai

DOI: https://doi.org/10.1136/oemed-2014-102407

IF: 4.9

2015-01-01

Occupational and Environmental Medicine

Abstract:Objectives Although the serum granulocyte-macrophage colony stimulating factor autoantibody (GMAb) levels have been recognised as a diagnostic marker in primary pulmonary alveolar proteinosis (PAP), their role in PAP with occupational inhalational exposure (PAPo) remains unclear.Methods Forty-five consecutive patients with PAP were enrolled. Each patient with PAP was assessed for baseline clinical characteristics, chest high-resolution CT (HRCT), serum GMAb and occupational exposure. Fifty healthy controls were included to define normal ranges for GMAb levels. Ninety-seven hospital controls with other respiratory diseases were included to establish prevalence of a history of occupational inhalation exposure.Results According to the serum GMAb cut-off value of 2.39 mu g/mL, 84.4% of the recruited patients with PAP had positive serum GMAb with a median level of 28.7 mu g/mL, defined as autoimmune PAP, and the remaining 15.6% had negative serum GMAb with a median level of 0.16 mu g/mL, defined as nonautoimmune PAP. Also, 34.2% of patients with autoimmune PAP had a history of occupational inhalational exposure, which was not significantly higher than that of hospital controls (34.2% vs 19.6%, p=0.072). Four patients with PAPo showed negative GMAb. Their arterial oxygen tension, pulmonary function parameters and chest HRCT features were significantly different when compared with patients with autoimmune PAP (p<0.05). These four non-autoimmune occupational lung disease cases culminated in 3 deaths and a lung transplant.Conclusions A number of patients with PAP who may have occupational inhalational exposure and negative serum GMAb represent a high possibility of silicoproteinosis and very poor survival.